The University of Southampton
University of Southampton Institutional Repository

Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge

Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge
Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge

While immunoglobulin (Ig) E is a prominent biomarker for early-onset, its levels are often elevated in non-allergic late-onset asthma. However, the pattern of IgE expression in the latter is mostly polyclonal, with specific IgEs low or below detection level albeit with an increased total IgE. In late-onset severe asthma patients, specific IgE to Staphylococcal enterotoxins (SE-IgE) can frequently be detected in serum, and has been associated with asthma, with severe asthma defined by hospitalisations, oral steroid use and decrease in lung function. Recently, SE-IgE was demonstrated to even predict the development into severe asthma with exacerbations over the next decade. Staphylococcus aureus manipulates the airway mucosal immunology at various levels via its proteins, including superantigens, serine-protease-like proteins (Spls), or protein A (SpA) and possibly others. Release of IL-33 from respiratory epithelium and activation of innate lymphoid cells (ILCs) via its receptor ST2, type 2 cytokine release from those ILCs and T helper (Th) 2 cells, mast cell degranulation, massive local B-cell activation and IgE formation, and finally eosinophil attraction with consequent release of extracellular traps, adding to the epithelial damage and contributing to disease persistence via formation of Charcot–Leyden crystals are the most prominent hallmarks of the manipulation of the mucosal immunity by S. aureus. In summary, S. aureus claims a prominent role in the orchestration of severe airway inflammation and in current and future disease severity. In this review, we discuss current knowledge in this field and outline the needs for future research to fully understand the impact of S. aureus and its proteins on asthma.

0903-1936
1-12
Bachert, Claus
a690b520-a2fc-4519-ac35-c61f093f6cfc
Humbert, Marc
4810a9ae-540b-4b74-a72e-df68dbea47d3
Hanania, Nicola A.
3dc51be1-4634-4d14-a27b-cd2ad16c57fe
Zhang, Nan
d3fed8fc-9e3c-4a0b-9701-c3213e47cdf6
Holgate, Stephen
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Buhl, Roland
05200fd4-c811-4bdc-8474-8ac835a0292b
Bröker, Barbara M.
545ba95c-8e7c-4859-88f2-1139052e9c46
Bachert, Claus
a690b520-a2fc-4519-ac35-c61f093f6cfc
Humbert, Marc
4810a9ae-540b-4b74-a72e-df68dbea47d3
Hanania, Nicola A.
3dc51be1-4634-4d14-a27b-cd2ad16c57fe
Zhang, Nan
d3fed8fc-9e3c-4a0b-9701-c3213e47cdf6
Holgate, Stephen
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Buhl, Roland
05200fd4-c811-4bdc-8474-8ac835a0292b
Bröker, Barbara M.
545ba95c-8e7c-4859-88f2-1139052e9c46

Bachert, Claus, Humbert, Marc, Hanania, Nicola A., Zhang, Nan, Holgate, Stephen, Buhl, Roland and Bröker, Barbara M. (2020) Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge. European Respiratory Journal, 55 (4), 1-12, [1901592]. (doi:10.1183/13993003.01592-2019).

Record type: Article

Abstract

While immunoglobulin (Ig) E is a prominent biomarker for early-onset, its levels are often elevated in non-allergic late-onset asthma. However, the pattern of IgE expression in the latter is mostly polyclonal, with specific IgEs low or below detection level albeit with an increased total IgE. In late-onset severe asthma patients, specific IgE to Staphylococcal enterotoxins (SE-IgE) can frequently be detected in serum, and has been associated with asthma, with severe asthma defined by hospitalisations, oral steroid use and decrease in lung function. Recently, SE-IgE was demonstrated to even predict the development into severe asthma with exacerbations over the next decade. Staphylococcus aureus manipulates the airway mucosal immunology at various levels via its proteins, including superantigens, serine-protease-like proteins (Spls), or protein A (SpA) and possibly others. Release of IL-33 from respiratory epithelium and activation of innate lymphoid cells (ILCs) via its receptor ST2, type 2 cytokine release from those ILCs and T helper (Th) 2 cells, mast cell degranulation, massive local B-cell activation and IgE formation, and finally eosinophil attraction with consequent release of extracellular traps, adding to the epithelial damage and contributing to disease persistence via formation of Charcot–Leyden crystals are the most prominent hallmarks of the manipulation of the mucosal immunity by S. aureus. In summary, S. aureus claims a prominent role in the orchestration of severe airway inflammation and in current and future disease severity. In this review, we discuss current knowledge in this field and outline the needs for future research to fully understand the impact of S. aureus and its proteins on asthma.

This record has no associated files available for download.

More information

Accepted/In Press date: 31 December 2019
e-pub ahead of print date: 3 April 2020
Published date: April 2020
Additional Information: Copyright ©ERS 2020.

Identifiers

Local EPrints ID: 441711
URI: http://eprints.soton.ac.uk/id/eprint/441711
ISSN: 0903-1936
PURE UUID: cc94ab10-9b51-4c55-bb49-bf0d8f4c5c78

Catalogue record

Date deposited: 24 Jun 2020 16:30
Last modified: 17 Mar 2024 12:40

Export record

Altmetrics

Contributors

Author: Claus Bachert
Author: Marc Humbert
Author: Nicola A. Hanania
Author: Nan Zhang
Author: Stephen Holgate
Author: Roland Buhl
Author: Barbara M. Bröker

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×